Short Interest in Trupanion, Inc. (NASDAQ:TRUP) Expands By 15.6%

Posted by on May 15th, 2023

Trupanion, Inc. (NASDAQ:TRUP – Get Rating) was the target of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 11,040,000 shares, an increase of 15.6% from the April 15th total of 9,550,000 shares. Based on an average daily trading volume, of 1,010,000 shares, the days-to-cover ratio is currently 10.9 days. Currently, 31.2% of the company’s shares are short sold.

Trupanion Stock Down 5.1 %

Trupanion stock opened at $21.16 on Monday. The firm has a market cap of $872.32 million, a price-to-earnings ratio of -14.30 and a beta of 1.70. The stock has a fifty day simple moving average of $40.93 and a two-hundred day simple moving average of $49.20. Trupanion has a 12 month low of $20.80 and a 12 month high of $82.49. The company has a current ratio of 1.64, a quick ratio of 1.62 and a debt-to-equity ratio of 0.35.

Trupanion (NASDAQ:TRUP – Get Rating) last posted its earnings results on Thursday, May 4th. The financial services provider reported ($0.60) EPS for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.32). The business had revenue of $256.33 million during the quarter, compared to the consensus estimate of $251.88 million. Trupanion had a negative return on equity of 19.86% and a negative net margin of 6.34%. Equities analysts predict that Trupanion will post -1.19 EPS for the current fiscal year.

Analyst Ratings Changes

TRUP has been the subject of a number of research analyst reports. Lake Street Capital lowered their target price on Trupanion from $75.00 to $47.00 in a research note on Friday, May 5th. Bank of America cut Trupanion from a “buy” rating to a “neutral” rating and lowered their target price for the company from $72.00 to $32.00 in a research note on Sunday, May 7th. StockNews.com assumed coverage on Trupanion in a research note on Thursday, March 16th. They issued a “sell” rating for the company. Jefferies Financial Group lowered their price objective on Trupanion from $75.00 to $65.00 and set a “buy” rating for the company in a research note on Tuesday, March 28th. Finally, Canaccord Genuity Group lifted their price objective on Trupanion from $66.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, February 16th. One analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $57.10.

Insiders Place Their Bets

In other Trupanion news, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Tuesday, February 28th. The stock was sold at an average price of $58.10, for a total value of $232,400.00. Following the completion of the sale, the chief executive officer now owns 845,109 shares in the company, valued at approximately $49,100,832.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Trupanion news, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Tuesday, February 28th. The stock was sold at an average price of $58.10, for a total value of $232,400.00. Following the completion of the sale, the chief executive officer now owns 845,109 shares in the company, valued at approximately $49,100,832.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Michael Doak sold 2,750 shares of the stock in a transaction that occurred on Tuesday, March 28th. The stock was sold at an average price of $40.00, for a total value of $110,000.00. Following the completion of the sale, the director now owns 1,682 shares of the company’s stock, valued at approximately $67,280. The disclosure for this sale can be found here. In the last 90 days, insiders sold 26,250 shares of company stock worth $1,176,975. 5.86% of the stock is currently owned by company insiders.

Institutional Trading of Trupanion

Institutional investors and hedge funds have recently modified their holdings of the business. Cerity Partners LLC bought a new stake in shares of Trupanion in the 1st quarter worth $970,000. Lindbrook Capital LLC grew its holdings in shares of Trupanion by 95.6% in the fourth quarter. Lindbrook Capital LLC now owns 573 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 280 shares during the period. Strs Ohio bought a new stake in shares of Trupanion in the third quarter worth $35,000. Captrust Financial Advisors grew its holdings in shares of Trupanion by 162.6% in the first quarter. Captrust Financial Advisors now owns 893 shares of the financial services provider’s stock worth $80,000 after acquiring an additional 553 shares during the period. Finally, Quadrant Capital Group LLC grew its holdings in shares of Trupanion by 235.7% in the fourth quarter. Quadrant Capital Group LLC now owns 940 shares of the financial services provider’s stock worth $45,000 after acquiring an additional 660 shares during the period. Institutional investors own 97.55% of the company’s stock.

Trupanion Company Profile

(Get Rating)

Trupanion, Inc engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members.

Featured Articles

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.